Skip to content
ok-min

Manij Joshi

Clinical Pharmacist

Manij serves as a trial pharmacist on the multi-country, double-blinded, randomized controlled trial ACT South Asia at OUCRU.

His research interests include infectious diseases, antimicrobial use and resistance, antihypertensive drugs, and oral hypoglycemic drugs.

In addition to his role as a trial pharmacist, Manij works as a QA officer in a cohort study that follows a randomized controlled trial. The study is titled ‘Assessing the medium-term impact of a Vi-polysaccharide conjugate vaccine in preventing typhoid infections among Nepali children.”

Furthermore, Manij also worked as a vaccine logistics officer in a double-blinded randomized controlled trial of the Typhoid Conjugate Vaccine (TCV) from December 19, 2019, to March 31, 2022. The study is titled ‘Assessing the impact of Vi-polysaccharide conjugate vaccine in preventing typhoid infections among Nepali children – a phase III trial.’

Timeline

Qualification

Master’s Degree in Pharmaceutical Care

Publications

Loading...
Mila Shakya, Merryn Voysey, Katherine Theiss-Nyland, Rachel Colin-Jones, Dikshya Pant, Anup Adhikari, Susan Tonks, Yama F Mujadidi, Peter O’Reilly, Olga Mazur, Sarah Kelly, Xinxue Liu, Archana Maharjan, Ashata Dahal, Naheeda Haque, Anisha Pradhan, Suchita Shrestha, Manij Joshi, Nicola Smith, Jennifer Hill, Jenny Clarke, Lisa Stockdale, Elizabeth Jones, Timothy Lubinda, Binod Bajracharya, Sabina Dongol, Abhilasha Karkey, Stephen Baker, Gordan Dougan, Virginia E Pitzer, Kathleen M Neuzil, Shrijana Shrestha, Buddha Basnyat, Andrew J Pollard; TyVAC Nepal Team
Lancet Glob Health
November 1, 2021
DOI: 10.1016/S2214-109X(21)00346-6
Shakya M, Colin-Jones R, Theiss-Nyland K, Voysey M, Pant D, Smith N, Liu X, Tonks S, Mazur O, Farooq YG, Clarke J, Hill J, Adhikari A, Dongol S, Karkey A, Bajracharya B, Kelly S, Gurung M, Baker S, Neuzil KM, Shrestha S, Basnyat B, Pollard AJ; TyVAC Nepal Study Team
N Engl J Med
December 5, 2019
DOI: 10.1056/NEJMoa1905047